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Abstract
Previous studies revealed a significant production of inflammatory cytokines together with severe thymic atrophy and
thymocyte migratory disturbances during experimental Chagas disease. Migratory activity of thymocytes and mature T cells
seem to be finely tuned by cytokines, chemokines and extracellular matrix (ECM) components. Systemic TNF-a is enhanced
during infection and appears to be crucial in the response against the parasite. However, it also seems to be involved in
disease pathology, since it is implicated in the arrival of T cells to effector sites, including the myocardium. Herein, we
analyzed the role of TNF-a in the migratory activity of thymocytes in Trypanosoma cruzi (T. cruzi) acutely-infected mice. We
found increased expression and deposition of TNF-a in the thymus of infected animals compared to controls, accompanied
by increased co-localization of fibronectin, a cell migration-related ECM molecule, whose contents in the thymus of infected
mice is also augmented. In-vivo studies showed an enhanced export of thymocytes in T. cruzi-infected mice, as ascertained
by intrathymic injection of FITC alone or in combination with TNF-a. The increase of immature CD4
+CD8
+ T cells in
secondary lymphoid organs was even more clear-cut when TNF-a was co-injected with FITC. Ex-vivo transmigration assays
also revealed higher number of migrating cells when TNF-a was added onto fibronectin lattices, with higher input of all
thymocyte subsets, including immature CD4
+CD8
+. Infected animals also exhibit enhanced levels of expression of both
mRNA TNF-a receptors in the CD4
+CD8
+ subpopulation. Our findings suggest that in T. cruzi acute infection, when TNF-a is
complexed with fibronectin, it favours the altered migration of thymocytes, promoting the release of mature and immature
T cells to different compartments of the immune system. Conceptually, this work reinforces the notion that thymocyte
migration is a multivectorial biological event in health and disease, and that TNF-a is a further player in the process.
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Introduction
Trypanosoma cruzi is the etiologic agent of Chagas disease. Despite
substantial progress over the last years in relation to the
immunopathology of the disease, the role of the thymus in the
courseofinfectionand pathogenesisremainsunclear.Severethymic
alterations were observed during experimental Trypanosoma cruzi-
acute infection. Thymuses in infected mice develop a progressive
atrophy, mainly due to a depletion of CD4
+CD8
+ double-positive
thymocytes[1,2].SuchCD4
+CD8
+celldepletionseemstobelinked
to a severe stress-triggered apoptosis [3]. Nevertheless, other
simultaneous mechanisms of cell loss may take place, as for example
a decrease in the arrival of bone marrow-derived precursors and/or
an increase in thymocyte export. Recent data confirmed an altered
intrathymic migration of thymocytes along with an atypical
presence of immature CD4
+CD8
+ cells bearing prohibited TCR
Vb segments in secondary lymphoid organs [4–6]. These functional
abnormalities were accompanied by an increase in the deposition of
extracellular matrix proteins (ECMs) in cortex and medulla of the
thymic lobules, and by a rise in the expression of their receptors in
thymocyte subpopulations and peripheral CD4
+CD8
+ cells [4–7].
Furthermore, the anomalous exit of CD4
+CD8
+ cells seems to be
influenced by the interaction between fibronectin and the
chemokine CXCL12 [5].
The role of tumor necrosis factor-alpha (TNF-a)i nT. cruzi
infection seems to be dual. Control of human and experimental T.
cruzi infection is critically dependent on TNF-a activity but its
overproduction is detrimental to the host and contributes to
disease pathology [2,8–11]. The contribution of TNF-a to the T.
cruzi-triggered thymic atrophy is at least partly dependent on
hypothalamus-pituitary-adrenal axis activation, which promoted
intrathymic apoptosis of CD4
+CD8
+ cells by exposure to increased
levels of adrenal glucocorticoid hormones [3,12].
Processes related to thymocyte migration could be also
mediated by TNF-a, but at present, data on a putative role of
TNF-a modulating cell migration in the thymus remains lacking.
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e34360Yet, this hypothesis seems plausible since in T. cruzi-infected mice,
TNF-a modulates migratory responses, inducing chemokine
expression at systemic level, probably down-regulating CCR5
expression [13,14]. We previously showed that in T. cruzi-infected
TNF-a receptor double knockout mice (p55
2/2 plus p75
2/2)
inflammatory infiltrates in the myocardium are absent [3],
suggesting that during T. cruzi infection migration of peripheral
T cells is influenced by TNF-a.
Under normal conditions, intrathymic cell migration and
thymocyte export are complex processes, regulated at least by
ECM proteins such as fibronectin and laminin, as well as
chemokines [15–17], sphingosine-1-phosphate [18,19], and hor-
mones [20–22]. Considering that TNF-a is capable of interacting
with fibronectin, promoting T cell adhesion [23], it is conceivable
that during the immune response induced by T. cruzi infection,
systemic or intrathymic production of TNF-a could modulate
thymocyte migration, either by itself or in combination with ECM
molecules, particularly fibronectin.
Taking into account previous results showing disturbances of
thymocyte migratory properties during T. cruzi infection in mice,
we explored herein the role of TNF-a in intrathymic T cell
migration, as well as thymocyte export to peripheral lymphoid
organs.
Materials and Methods
1. Mice and experimental infection
Male C57BL/6 mice, aging 6–8 weeks, were obtained from the
animal facilities at Rosario Medical School and Oswaldo Cruz
Foundation. All animal procedures were performed according to
protocols for animal care and use, approved by each Institutional
Ethical Committee (Fiocruz Ethics Committee, Comissa ˜o de E ´tica
no Uso de Animais (CEUA-Fiocruz), Resolution Nu P-0145-02;
and Faculty of Medical Sciences from National University of
Rosario, Bioethics and Biosecurity Committees, Resolution
Nu3740/2009). Trypomastigotes of the Tulahue ´n strain of T.
cruzi (Clonotype II) were maintained by serial passages in suckling
mice. Heparinized blood obtained from infected animals was
diluted in saline and washed twice. Live parasites were counted
using Neubauer chambers. Mice were infected subcutaneously
with 100 viable trypomastigotes. To monitor the systemic
repercussion of the acute disease, parasitaemia and the survival
time was recorded following infection as described before [3].
2. Flow cytometry analysis of cell suspensions
Thymuses, subcutaneous lymph nodes and spleens were
removed, minced, washed and resuspended in PBS containing
fetal calf serum 5% (Gibco, California, USA). Spleen samples were
further treated with NH4Cl for red cell lysis.
For immunostaining, 1.10
6 cells were resuspended in flow buffer
and incubated with a given specific monoclonal antibody for
30 minutes at 4uC in the dark (PE/anti-CD4, PercP/anti-CD8 or
TC/anti-CD8 antibodies, BD Pharmingen, San Diego, USA).
Once defined the lymphocyte gate, 30,000 events were acquired.
Background staining values obtained with fluorochrome matched-
conjugate isotype controls were subtracted.
For recent thymic emigrants (RTEs) determination (see below),
cells from mice injected with physiological saline alone were used
to define positive FITC labeling in the other groups.
In cell migration experiments, migrating cells were also labelled
with the appropriate antibodies, fixed with paraformaldehyde 1%
and analyzed by flow cytometry. Monoclonal antibodies used to
stain cell surface molecules were: PE/anti-CD4, PercP/anti-CD4,
PE/anti-CD8, PercP/anti-CD8, APC/anti-CD8, APC/anti-CD3
and PE/anti-TCR (BD Pharmingen). In all cases, dead cells were
gated out on the basis of forward- and side-cell scatter.
Fluorochrome-labeled isotype-matched negative controls for the
specific antibodies were also used (BD Pharmingen). Acquisition of
events was done using an FACSAria or FACScalibur flow
cytometers (BD Pharmingen). Results were analyzed using the
WinMDI 2.8 software (Joseph Trotter, CA, USA).
3. Determination of circulating and intrathymic TNF-a
contents
Mice were bled by cardiac puncture at different days post-
infection. Blood was centrifuged during 10 min at 1,500 rpm at
24uC. Serum was stored frozen at 220uC until analyzed. At the
same time, thymuses were removed, weighted and homogenized in
2 volumes of 300 mmol/L sucrose with protease inhibitors (1 mM
phenylmethylsulfonyl fluoride, 10 mg/ml leupeptin, and 1 mg/ml
aprotinin). Homogenates were kept at 280uC until used. TNF-a
concentrations were measured in blood and tissue samples by a
specific ELISA kit, according to manufacturer’s specifications (BD
Pharmingen). Detection limit of the technique corresponds to
15.6 pg/ml.
In further experiments, intrathymic TNF-a was detected by
means of immunoblotting. Lysates of thymuses were prepared in 4
volumes of 300 mmol/L sucrose with protease inhibitors: 1 mM
phenylmethylsulfonyl fluoride, 10 mg/ml leupeptin, and 1 mg/ml
aprotinin (Sigma Co, St. Louis, USA). Samples (20 mg of protein)
were subjected to electrophoresis under reducing conditions on a
15% SDS-PAGE, and transferred onto nitrocellulose membranes.
After blocking (5% non fat milk during 2 h at room temperature),
blots were incubated overnight at 4uC with rat anti-mouse TNF-a
monoclonal antibody (clone MP6-XT3). Membranes were then
incubated in blocking buffer with anti-rat Ig G-peroxidase
conjugate (1:5000, Amersham Life Science, Buckinghamshire,
UK) and bands were detected by enhanced chemiluminescence kit
(Amersham). Autoradiographs were obtained by exposing PVDF
membranes to Kodak XAR film, and the bands were quantitated
by densitometry, using a Shimadzu CS-9000 apparatus (Kyoto,
Japan).
4. In situ detection of TNF-a in the thymus
Thymuses were removed 14 days after infection, embedded in
Tissue-Tek (Miles Inc., Elkhart, USA) and frozen in liquid
nitrogen. Five 5 mm-thick cryostat sections were settled on poly-
L-lysine (Sigma)-covered glass slides, acetone fixed and blocked
with PBS-BSA 1%. Samples were submitted to specific antibodies
as follows: 1:10 rat anti-mouse TNF-a monoclonal antibody (1:10,
stock: 100 mg/mL, clone MP6-XT3 or rabbit anti-mouse
fibronectin (Novotec, Saint-Martin La Garenne, France) for
1 hour at room temperature, washed and submitted to appropri-
ate secondary antibody, 1:400 goat anti-rabbit Alexa 488 and
1:400 goat anti-rat Alexa 546 (Molecular Probes, Eugene, USA)
respectively. Samples were analyzed by confocal microscopy using
a LSM 510 Zeiss device (Germany) and the images obtained were
subsequently analyzed using the Image J software (Bethesda,
Maryland, USA).
5. Evaluation of recent thymic emigrants
Intrathymic injection of fluoresceinisothiocyanate (FITC) allows
direct in vivo evaluation of RTEs. FITC efficiently and randomly
labels thymocytes, enabling their subsequent identification in the
peripheral lymph organs. Intrathymic FITC injections were
performed as described by Scollay et al [24] with minor
modifications. Briefly, animals were anesthetized (ketamine-
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expose the thymus. A Hamilton syringe was used to inject
12.5 mL/lobe of a suspension containing TNF-a plus FITC or
FITC alone. Recombinant murine TNF-a (PeproTech, Mexico
City, Mexico) was diluted up to 200 pg/mL in 500 mg/mL FITC
(Sigma-Aldrich, St. Louis, USA). FITC suspension was prepared
from a saturated stock diluted in physiological saline. Control
group was injected with saline alone. After intrathymic injection,
the skin incision was closed and mice were allowed to recover
under a heat source. To evaluate RTEs, animals were sacrificed 24
post-injection, and thymuses, spleen as well as axillary and
inguinal subcutaneous lymph nodes were removed. Lymphoid
cells from each organ were suspended in PBS solution containing
5% fetal calf serum; being then labeled with the appropriate
antibodies for monitoring FITC
+CD4
+CD8
+ cells by flow
cytometry. Only animals with more than 50% of FITC
+
thymocytes were used for subsequent analysis. Peripheral cells
were considered RTEs when FITC
+ cells could be distinguished
from, comparing with animals that only received intrathymic
injection of saline. Data were evaluated as absolute numbers of
FITC
+ cells, and also through an index enabling to estimate the
overall rate of emigration (ORE), adjusted to the absolute number
of FITC
+CD4
+CD8
+ cells at the periphery, in relation to
corresponding secondary lymphoid organ cellularity and the
percentage of labelled cells observed in the thymus.
ORE~ AbsolutenumberofFITCzcells| ð
CellularityinperipherallymphoidorganÞ7
%ofFITCzcellsinthethymus ðÞ
6. Cell migration assay
We evaluated thymocyte migratory response to TNF-a adhered
to fibronectin. Briefly, inserts of 5 mm-pore size of transwell plates
(Corning Costar, Cambridge, USA) were coated with 10 mg/mL
of human fibronectin or 10 mg/ml BSA (Sigma) for 1 h at 37uC
and then unspecific binding sites were blocked with BSA 10 mg/
mL. Various concentrations of recombinant murine TNF-a (25 or
250 pg/mL) were diluted in 70 mL added to upper chamber,
allowing adhesion to fibronectin (or BSA) during 15 min at 37uC.
Unbound TNF-a was then removed by washing before adding
thymic cells. Thymocytes were obtained at 14 days post-infection
or from non-infected counterparts. Cells (2.5 10
6 thymocytes in
100 mL of RPMI-1% BSA) were then added in the upper
chambers. Migration medium was serum free, so that to avoid
serum-derived fibronectin or other soluble cell migration stimuli.
After 3 hours of incubation at 37uC in a 5% CO2 humidified
atmosphere, migration was defined by counting the cells that
migrated to the lower chambers containing migration medium
alone (RPMI-1% BSA). Migrating cells were ultimately counted,
labelled with appropriate antibodies and analyzed by flow
cytometry. Differences in intrinsic cytokinesis between displayed
thymocytes from infected or noninfected mice driven by TNF-a or
fibronectin (alone or in combination) were expressed after
subtracting the value recorded in wells containing BSA alone.
The percentage of each subset was used together with the total cell
counting to calculate absolute numbers of each lymphocyte subset
from each lymphoid organ. The results are presented in terms of
total thymocyte migration as well as the percentages of input seen
in each CD4/CD8-defined subpopulation, using the following
formula:
Input % ðÞ ~ Absolute number of migrating ð
cells with a given phenotype|100Þ7
Total number of migrating cells ðÞ
7. Expression of TNF-receptors in CD4/CD8-defined
thymocyte subpopulations
ExpressionofgenescodingforbothTNF-receptors(TNF-R1and
TNF-R2) was evaluated by real-time PCR. In each experimental
condition, thymocytes subsets were FACS isolated from three
pooled thymuses stained with anti-CD4 Percp and anti-CD8 APC
antibodies, in a MoFlocell sorter (DakoCytomation, Fort Collins,
CO). All subsets were enriched to a purity of greater than 98%.
After sorting, RNA was extracted using a commercially available kit
(RNA easy minikit, Qiagen, Courtaboeuf, France). Total RNA
concentrations were estimated by A260 measurement. First strand
cDNA synthesis was prepared with 0.5 mg total RNA, random
hexamer primer, and Superscript III reverse transcriptase (Invitro-
gen, Carlsbad, CA). For qPCR we used approximately 100 ng of
cDNA for each sample and SYBR Green Master Mix 2 (Applied
Biosystems, California, USA). cDNA was amplified using specific
murine primer sequences: 59-TCAAAGAGGAGAAGGCTGG-39
(FP) and 59-CACCAC AGCATACAGAATCG-39 (RP) for TNF-
R1; (59 TGTAGCATCCTGGCTATTCC-39 (FP) and 59-AT-
GAAGCAGTTCACCAGTCC-39 (RP) for TNF-R2 and 59-GC-
TACAGCTTCACCACCACAG-39 (FP) and 59-GGTCTTT-
ACGGATGTCAACGTC-39 (reverse) for ACTB (b-actin). All
reactions were performed in triplicate. After 45 cycles of
amplification, TNF-R1 and TNF-R2 expression in each cell subset
was normalized to the housekeeping gene ACTB (2
2DCt61,000)
[25], subsequent to the following primer efficiency analysis.
8. Statistical analyses
Differences in quantitative measurements were assessed by the
Kruskall-Wallis non parametric analysis of variance and Mann-
Whitney U test. Correlations were evaluated by Pearson test.
Results were expressed as mean 6 standard error (SE) unless
otherwise indicated. The GraphPad Instat 4.0 software (Graph-
Pad, California, USA) was applied for statistical analyses, and
differences were considered significant when p value was #0.05.
Results
Thymic atrophy in T. cruzi acutely-infected mice parallels
enhanced circulating and intrathymic contents of TNF-a
A progressive thymic atrophy characterized by a diminution in
the organ size (Fig. 1a) linked to a marked depletion of CD4
+CD8
+
thymocytes (data not shown) was seen along with infection in
C57BL/6 infected mice, thus confirming previous results. These
alterations occurred in parallel with a systemic and intrathymic
increase in TNF-a contents. TNF-a rising became evident 14 days
post-infection in both thymus extracts and serum (Fig. 1b–c–d).
Actually, there was a strong correlation between intrathymic and
systemic concentrations of TNF-a (p,0.01). Additionally, we
found that the higher intrathymic TNF-a contents inversely
correlated with the thymic relative weight and the relative
numbers of CD4
+CD8
+ cells, thymic parameters that declined
along infection (Table 1). Confocal microscopy confirmed a more
intense deposition of TNF-a both in cortex and medulla of thymic
lobules after infection (Fig. 1e–f).
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role in the atypical thymocyte exportation and considering
previous report showing that in acutely-infected BALBlc mice
the anomalous migration was linked to a higher deposition and
expression of fibronectin together with enhanced co-localization of
chemokines (Mendes-da-Cruz et al, 2006), we next evaluated
Figure 1. Enhanced circulating and intrathymic contents of TNF-a parallel the thymic atrophy in T. cruzi acutely-infected mice. A)
Representative picture showing two thymuses from healthy control mice (Co) and the progressive thymic atrophy after 14, 17 and 21 days of acute
infection; B) TNF-a protein detection in thymus homogenates by western blot. Representative photomicrographs showing TNF-a and b-actin
expression in two control mice (Co) and in two infected mice after 21 days post-infection (Inf); C) TNF-a concentrations in thymic homogenates
detected by ELISA at different days after infection and normalized to total protein contents. Bars represent the mean 6 SEM of three pools/day); D)
Systemic concentration of TNF-a along infection evaluated by ELISA. (n=5–8 mice/day); E) Confocal microscopy showing an enhancement in TNF-a
contents both in cortex and medulla of the thymic lobules, after 14 days of infection. Original magnification 4006. Small box is a representative
control staining in which an unrelated primary antibody was applied; F) Graphs correspond to relative quantification analysis of TNF-a deposition in
both cortex and medulla from 3–5 microscopic fields of thymuses from control (n=5) or 14 days-infected animals (n=5); G) Representative
immunofluorescence staining showing thymuses of infected mice: TNF-a expression (in red, left picture); fibronectin (FN) deposition (in green, middle
picture); co-localization of TNF-a and FN (right picture). Small boxes correspond to negative control where immune reaction was controlled by using
unrelated primary antibodies; H) Bars correspond to the percentages of TNF-a plus FN co-localization in thymuses from control mice compared with
infected counterparts. Significant differences are indicated as *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0034360.g001
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Confocal microscopy data showed that co-localization of TNF-a
and fibronectin was increased after infection (Fig. 1g–h).
TNF-a modulates thymocyte export in vivo
To better approach the possibility that TNF-a plays a role upon
migratory properties of thymocytes during acute T. cruzi infection,
we investigated thymocyte export in vivo, by means of intrathymic
FITC injection, alone or in combination with the cytokine.
Twenty-four hours following intrathymic injection, thymuses,
axillary and inguinal subcutaneous lymph nodes (SLN), as well
as spleens, were removed and the FITC
+ CD4/CD8-defined T
cell subsets were ascertained by cytofluorometry (Fig. 2). Fourteen
days after infection, there was a significant increase in absolute
numbers of FITC
+ cells in peripheral lymphoid organs, as
compared to noninfected counterparts. Such an increase could
be seen in infected mice injected with FITC alone or with FITC
plus TNF-a. When the thymus was injected with FITC alone,
absolute numbers of FICT
+CD4
+ and FITC
+CD8
+ simple positive
cells from T. cruzi-infected mice were increased in both spleen and
SLN, compared with noninfected controls. In addition,
FITC
+CD4
+CD8
+ cells were detected in secondary lymphoid
organs from infected mice. Moreover, in infected animals,
intrathymic injection of TNF-a plus FITC revealed an increase
in the numbers of FITC
+CD4
+ and FITC
+ CD4
+CD8
+ in the
spleen, when compared with the injection of FITC in the absence
of the cytokine. Differences in the absolute numbers of
FITC
+CD4
+ or FITC
+ CD4
+CD8
+ populations from infected
animals were not detected in the SLN. Also, the amounts of
FITC
+CD8
+ or FITC
+CD4
2CD8
2 populations remained un-
changed following injection with TNF-a plus FITC, compared
with FITC alone.
Taking into account that the absolute numbers of FITC
+ cells in
the periphery depends on the degree of labelling of the thymus, we
estimated the overall rate of emigration (ORE) by adjusting the
absolute number of FITC
+CD4
+CD8
+ cells in the periphery in
relation to the cellularity of a given peripheral lymphoid organ and
the percentage of labelled observed in thymus. As seen in Table 2,
the ORE was affected by the infection, increasing several times
their baseline values, independently whether the thymus were
injected or not with TNF-a Interestingly, TNF-a plus FITC
injection caused a marked increase in the ORE of
FITC
+CD4
+CD8
+ cells compared with FITC alone in both
secondary lymphoid organs of infected animals. We did not notice
differences in values from FITC
+CD4
+ RTEs in the spleen after
TNF-a intrathymic injection, but, evaluation of ORE values
suggest a TNF-a-driven enhancement of FITC
+CD4
+ and
FITC
+CD8
+ cells in the lymph nodes from infected mice.
TNF-a modulates fibronectin-driven ex-vivo migratory
response of thymocytes
TNF-a lacks chemotactic activity by itself when placed in its
soluble form in the bottom well of transwell cell migration
chambers. Accordingly, migratory activity of thymocytes through
membranes treated with BSA plus TNF-a was similar to that seen
on BSA alone (data not shown).
To evaluate a haptotactic capacity of TNF-a, the recombinant
cytokine was placed in the upper chamber 15 min before adding
thymocytes. This procedure allows TNF-a to be deposited on the
pre-formed fibronectin lattice. As previously reported [5], there is
a higher fibronectin-driven migratory capacity of thymocytes from
infected animals than the corresponding controls. Herein, we also
showed that thymocytes from infected animals migrate more
through fibronectin plus TNF-a than fibronectin alone (Fig. 3a).
Thymocytes from infected animals also migrated more on
fibronectin when the cytokine was added at a low concentration,
namely 25 pg/mL. Nevertheless, compared with fibronectin
alone, we found no statistically differences in the absolute numbers
of migrating cells when 250 pg/mL TNF-a were added onto the
fibronectin lattice (for comparison of fibronectin versus fibronectin
plus TNF 250 pg/mL in both control and infected groups, we
found p=0.06).
For a more precise interpretation of these data, we evaluated
the specific migration of CD4/CD8-defined thymocyte subsets
(expressed as percentage of input for each subset), taking into
account that the relative amounts of distinct CD4/CD8-defined
thymocyte subpopulations changed after infection. We noticed
that CD4
+ cells from infected mice have a significantly higher
migratory response than non-infected animals when they
migrated through fibronectin alone, or through fibronectin plus
25 pg/mL TNF-a coated wells (group referred as FN+TNF25)
(Fig. 3b). Furthermore, when this TNF-a concentration was
added onto fibronectin, migratory responses of CD4
+,C D 8
+ as
well as CD4
2CD8
2 and CD4
+CD8
+ cells from infected animals
were significantly enhanced compared with fibronectin alone,
suggesting a co-stimulatory effect of the cytokine upon the
fibronectin-driven migration of these thymocyte subsets. Inter-
estingly, no differences were seen in the percentages of input,
when thymocytes from control animals migrated through
fibronectin plus TNF-a (independently of the concentration
applied) compared with fibronectin alone; suggesting that TNF-a
interacts with fibronectin mobilizing thymocytes from infected
but not from control animals.
Gene expression of TNF receptors in thymocytes from T.
cruzi infected mice
The enhanced migratory response of thymocyte subpopulations
in T. cruzi infected mice might be related to the enhanced
expression of integrin-type fibronectin receptors VLA-4 and VLA-
5 [4], as well as the TNF-a receptors. We further compared the
changes in the levels of TNF-R1 and TNF-R2 gene transcripts,
ascertained herein by p55 and P75 gene expression respectively, in
each CD4/CD8-defined subpopulation obtained from thymuses
of control or infected animals (14 days post-infection). Based on
the real-time RT-PCR analysis, a slight, yet significant induction
of both receptors was detected in DP cells of T. cruzi infected mice.
By contrast, TNF-R1 or TNF-R2 mRNA were similar in CD4
+ or
CD8
+ subpopulations, independently of whether they derived
from infected or control animals. Interestingly, in both conditions,
the amounts of TNF-R1 and –R2 transcripts on the DP subset
seemed greater than in SP cells, with a higher expression of the
isoform 2 of this receptor (Fig. 4).
Table 1. Correlation analyses for TNF-a thymic
concentrations and atrophy parameters in T. cruzi acutely
infected mice.
Correlation between
TNF-a thymic contents
(pg/50 mg tissue) Rho n
Serum TNF-a (pg/ml) p,0.015 0.890 18
RTW p,0.001 20,693 18
%D P p ,0.001 20.854 18
RTW=relative thymic weight (thymic weight/corporal weight); DP=CD4
+CD8
+
double positive cells; rho=Spearman correlation coefficient, n=number of XY
pairs.
doi:10.1371/journal.pone.0034360.t001
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+CD8
+ thymocytes. Control and 14 days-infected animals were intrathymically injected with FITC
dissolved in PBS with or without TNF-a. Twenty-four hours later, recent thymic emigrants (RTEs) were recognized as FITC
+/CD4
+/CD8
+ cells in
secondary lymphoid organs (spleen and subcutaneous lymph nodes) by flow cytometry. Empty bars represent the absolute number of FITC
+ cells
(610
3) from PBS injected mice and black bars represent the absolute number of FITC
+ cells from TNF-a injected animals. Results show that after
infection, the numbers of RTEs are clearly enhanced, independently of whether intrathymic injection of TNF-a was applied or not. When considering
CD4/CD8-defined subpopulations, we found that intrathymic inoculation of TNF-a further promoted a significant enhancement in the numbers of
FITC
+CD4
+ and FITC
+CD4
+CD8
+ cell in the spleen, but not in lymph nodes. Data depict a representative experiment of two similar ones; each
experiment being done with 5–6 animals/group. Statistically significant differences are indicated as *p,0.05.
doi:10.1371/journal.pone.0034360.g002
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Thymic atrophy occurs in a variety of infectious diseases,
including, among others, AIDS, malaria, syphilis and T. cruzi
infection [26]. Such atrophy derives from massive thymocyte
depletion, and results in changes in thymocyte export with
consequences upon the peripheral T-cell pool and the corre-
sponding T cell repertoire. Previous data strongly indicate that the
thymic involution during T. cruzi infection disrupts the homeostasis
of the organ, leading to an aberrant output of developing T cells,
which likely bypassed intrathymic negative selection events
[4,5,27], and might be involved in the generation of autoimmu-
nity. Yet, a definitive link between thymic functional abnormalities
and the autoimmune events occurring in Chagas disease remains
to be demonstrated.
Most of the information concerning the role of TNF-a is related
to induction of apoptosis [28–30]. However, our previous data
obtained in TNR-receptor double knockout mice revealed that
TNF-a is not required to induce thymocyte apoptosis during acute
T. cruzi infection. Nevertheless, the putative role of TNF-a in
thymocyte migration has not been investigated. Herein, we
examined the characteristics of thymic atrophy and thymic
migratory events in T. cruzi acutely infected animals, in relation
to the systemic and the intrathymic contents of TNF-a.
The results described above on traffic abnormalities in the more
immature thymocyte subpopulations, mainly CD4
+CD8
+ cells, but
also CD4
2CD8
2, cells unravel some relationship with an
enhancement in the contents of TNF-a complexed with
fibronectin, accompanied by the upregulation of the correspond-
ing receptors.
We first showed that intrathymic and systemic contents of TNF-
a were enhanced in acute T. cruzi infection. In this respect, it is
noteworthy that chronically-infected patients also exhibit aug-
mented TNF-a serum levels [31]. In this respect, it is plausible to
conceive that sustained high levels of the cytokine remain from the
acute to the chronic phase during the evolution of Chagas disease.
Interestingly, during T. cruzi infection, an increased TNF-a
expression was also observed in the thymus of offsprings and
foetuses from T. cruzi-chronically infected mothers [32] as well as
thymuses from animals treated with trans-sialidase, a T. cruzi
virulence factor [33]. Furthermore, the decline in TNF-a levels, as
a result of LPS desensitization, ameliorates the loss of cortical
CD4
+CD8
+ cells during acute T. cruzi infection [10].
Besides the increase in the intrathymic contents of TNF-a and
fibronectin in infected animals, we found enhanced co-localization
of these molecules within the organ. This finding is in line with
studies by Alon and co-workers [23], showing that when TNF-a is
expressed in high amounts in inflamed tissues it forms complexes
with fibronectin.
This TNF-a/fibronectin interaction seems to have functional
implications in T cell migration during T. cruzi infection, since low
doses of TNF-a pre-bound to fibronectin, induced an increase in
the export of mature CD4
+ and CD8
+ as well as CD4
2CD8
2
immature thymocyte subsets. Furthermore, in vivo intrathymic
injection of TNF-a resulted in an increase in the numbers of
RTEs, including immature double-positive cells, thus suggesting
an abnormal fluctuation in thymocyte export, which could be link
to the autoimmune events seen in chagasic mice and humans.
Other possibility to explain these data is that in vivo TNF-a binding
to fibronectin favours in thymocytes, the integration with other cell
migration-related signals, such as chemokines, for example, enabling
Table 2. Overall rate of emigration (ORE) after intrathymic inoculation.
ORE Spleen Subcutaneous Lymph Nodes
FITC alone TNF-a+FITC FITC alone TNF-a+FITC
Total RTEs
Control 3.360.5 8.062.0 3.060.8 5.060.10
T. cruzi 204.7634.7
(**) 314.6679.6
(**) 99.5 631.6
(**) 170.8631.7
(**)
CD4
+ cells
Control 1.660.4 2.461.4 0.0360.01 0.0560.01
T. cruzi 88.4632.0
(**) 137.068.0
(**) 1.1560.25
(**) 1.7060.28
(**); (DD)
CD8
+ cells
Control 0.860.3 0.760.1 2.160.1 2.260.4
T. cruzi 28.668.9
(**) 37.064.9
(**) 57.0618.0
(**) 88.7611.8
(**); (D)
CD4
+CD8
+ cells
Control 0.160.0 0.660.3 0.060.0 0.460.3
T. cruzi 11.864.5 25.063.9
(**); (DD) 1.060.3
(**) 1.8060.02
(**); (D)
CD4
2CD8
2 cells
Control 1.3 060.1 4.962.1 2.860.9 4.860.1
T. cruzi 72.0645.0 158.2675.0 94.5633.8
(**) 161.3636.2
(**)
Control and 14 days-infected animals were injected intrathymically with FITC or FITC plus TNF-a. Twenty-four hours after, thymuses, spleens and subcutaneous lymph
nodes were screened for FITC
+ CD4/CD8-defined cell subsets and these data were adjusted in relation to the cellularity of each peripheral lymphoid organ and the
percentage of thymus labelling, using the following formula: Overall rate of emigration (ORE)=(Absolute numbers of FITC
+ cells6cellularity in the peripheral lymphoid
organ)/(% of FITC
+ cells in thymus). We verified an enlarged ORE values in infected animals, independently of whether they were inoculated or not with TNF-a.D a t a
indicate that TNF-a promotes the output of immature DP
+ cells to both spleen and subcutaneous lymph nodes. Absolute numbers of FITC
+ cells, CD4
+, CD8
+ and DN
cells was expressed on 1.10
4 cells, while DP
+ cells was expressed on 1.10
3 cells. Cellularity of each peripheral lymphoid organ was expressed in 1.10
6 cells. Values are
mean 6 SEM of 5–6 mice/group (one representative experiment of two independent series). Difference between Control versus T. cruzi group=
(*
)p,0.05;
(**
)p,0.02.
Differences between TNF-a treated versus not treated group=
(D)p,0.05;
(DD)p,0.02.
doi:10.1371/journal.pone.0034360.t002
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which is clearly disorganized during acute infection. Future studies on
the combined effects of TNF-a with other fibronectin-binding
chemokine(s), as CXCL12, should be informative.
Our study is at variance with previous observations, in which
TNF-a was proposed as a stop signal for leukocyte migration [34].
Most likely however, the differences in the procedures applied for
studying cell migration and the experimental conditions used in
Figure 3. TNF-a enhances in vitro fibronectin-driven migration of thymocytes from T. cruzi infected mice. A) Thymocytes from control or
infected animals were allowed to migrate in transwell chambers coated with fibronectin (FN) alone or FN plus TNF-a. Fibronectin-induced haptotactic
response of thymocytes from infected animals was enhanced compared with controls in presence of TNF-a at the concentration of 25 pg/mL. Results
derive from four experiments for TNF-25 pg/mL and three for TNF-250 pg/mL (each one obtained by pools of at least 3–4 animals by group) and
correspond to specific migration after subtracting absolute cell numbers obtained in each well coated only with BSA. Statistically significant
differences are indicated as p,0.05. B) Specific migration of thymocyte subpopulations was expressed as percentage of input (see Material and
Methods session). We observed an enhanced migratory response of CD4
+, CD8
+, DP and DN cells when TNF-a was applied at 25 pg/mL, as compared
with FN alone in infected animals. Results derived from four experiments, each one obtained by pools of at least 3–4 animals by group. Data
correspond to specific migration after subtracting absolute cell numbers obtained in each well coated only with BSA. Statistically significant
differences are indicated as *p,0.05 and **p,0.01.
doi:10.1371/journal.pone.0034360.g003
TNF-a and Abnormal Migration in T. cruzi Infection
PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e34360these assays account for such discrepancy. For example, we used
thymocytes and not naı ¨ve peripheral T cells for functional assays.
A relevant aspect derived from our results is that, both in vivo
and in vitro, immature CD4
2CD8
2 as well as CD4
+CD8
+ cells
displayed a higher migratory response to fibronectin in the
presence of TNF-a. These results not only confirm higher
fibronectin-driven immature cell migration during the acute phase
of infection [4,5], but also place TNF-a as co-stimulatory moiety
for migratory responses triggered by the ECM protein.
We have previously proposed that thymocyte migration (both in
health and disease) is a multivectorial event, from the action of
various ligand/receptor interactions; each one corresponding to a
single migration vector [35]. The results presented herein show
that intrathymic T cell migration is still more complex, since the
TNF-a mediated interactions, although not being able to induce
thymocyte migration per se, enhance fibronectin-triggered migra-
tory response of these cells. In acutely-infected mice, the ultimate
migration patterns reveal the abnormal release of immature
CD4
+CD8
+ lymphocytes towards secondary lymphoid organs.
Previous work strongly indicates that part of these immature cells
released from the thymus in T. cruzi infected animals is potentially
autoimmune, since they have bypassed the classic intrathymic
negative selection [5,40]. More recently, we showed that such a
skewed negative selection is not due to an intrinsic defect of the
thymic microenvironmental machinery, since thymic epithelial
cell function seems normal in terms of AIRE (autoimmune
regulator) and tissues restricted antigen gene expression [27].
Accordingly, it is conceivable that the release of immature cells
from the thymus into the periphery is rather a cell migration-
related disturbance.
In any case, the release of potentially autoimmune T cells may
result in the development of autoimmunity, even in adult
individuals. Importantly, recent data suggest that the occurrence
of immature T cells in the periphery of the immune system is
extended during chronic phase in both mice and patients infected
with T. cruzi [4,27,40].
The enhanced CD4
+CD8
+ cell homing to secondary lymphoid
organs might be related to a selective expression of fibronectin
receptors (VLA-4 and VLA-5) and also with TNF-receptors
(TNF-R1 and TNF-R2). Accordingly, during T. cruzi infection,
VLA-4 and VLA-5 are enhanced in CD4
+CD8
+ cells [4]. As
ascertained by cell sorting of thymic subpopulations followed by
qPCR, 14 days after infection, animals also exhibited enhanced
expression levels of both mRNA TNF-a receptors in the
CD4
+CD8
+ subpopulation, when we observed an increased
export of this subset modulated by intrathymic TNF-a contents.
Moreover, the relative amount of mRNA TNF-R2 seems to be
higher than the TNF-R1 in these cells. This is in keeping with the
putative role of TNF-R2 in cell migration events [36,37], while
TNF-R1 is believed to be more related to induction of apoptosis
[28–30]. Overall, these data suggest that CD4
+CD8
+ cell
migration may be favored by up-regulation of fibronectin and
TNF-a receptors.
T cells are crucial in protective immunity against T. cruzi, but at
the same time are involved in the autoimmune phenomenon seen
in chronic Chagas disease [38,39]. In this respect, our results
reinforce the idea that the autoimmune component in Chagas
disease may be partly related to the intrathymic migratory
abnormalities with consequent export of immature cells. In this
context, we unravelled herein the role of TNF-a mediated
interactions in this overall process. Yet, the precise contribution
of immature thymocytes to the immunopathological events
occurring in Chagas disease deserves further investigation.
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Figure 4. Expression of TNF-R1 and TNF-R2 en CD4
+, CD8
+ and
CD4
+CD8
+ (DP) thymocytes. DP and SP T cells were purified from
thymuses of control and acutely infected mice (14 days post-infection)
by cell sorting using flow cytometry. To quantitatively evaluate TNFR
transcripts, total mRNA samples from highly purified fresh DP, CD4+
and CD8+ T cells were processed for quantitative RT-PCR. The relative
gene expression of mRNA of TNF-R1 and TNF-R2 were enhanced in DP
thymocytes from infected animals compared with controls. Results are
presented as relative gene expression, where mRNA levels were
calculated using the equation 2
2DCt (difference in Ct between b-actin
and the target gene). Data depict a representative experiment.
Statistically significant differences are indicated as *p,0.05.
doi:10.1371/journal.pone.0034360.g004
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